Correlia Biosystems nabs $7 million in series A financing
The Berkeley, Calif.-based company expects to begin offering a commercial version of its assays in the third quarter of 2021, Apori told BioWorld.
Read More- CV-19 Press
Stay Up To Date with COVID-19 Data
More than 22 million Americans have contracted the virus. Get the latest headlines from the Coronavirus Press today.
